Aciex Therapeutics

Westborough, United States Founded: 2007 • Age: 19 yrs Acquired By Nicox
Therapeutics for ophthalmic allergy and inflammation were developed.

About Aciex Therapeutics

Aciex Therapeutics is a company based in Westborough (United States) founded in 2007 was acquired by Nicox in July 2014.. Aciex Therapeutics has raised $9.6 million across 2 funding rounds from investors including Nicox and Akorn. Aciex Therapeutics operates in a competitive market with competitors including Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others.

  • Headquarter Westborough, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $9.6 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.6 M (USD), Series A

    Apr 22, 2014

  • Investors
    Nicox

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Nicox

    (Jul 02, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Aciex Therapeutics

Aciex Therapeutics has successfully raised a total of $9.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.6 million completed in April 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $1.6M
  • First Round

    (02 Aug 2011)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2014 Amount Series A - Aciex Therapeutics Valuation

investors

Aug, 2011 Amount Series A - Aciex Therapeutics Valuation Akorn
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aciex Therapeutics

Aciex Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Nicox and Akorn. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Injectable and ophthalmic pharmaceutical products were manufactured across therapeutic areas.
Founded Year Domain Location
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aciex Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aciex Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aciex Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aciex Therapeutics

Aciex Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of antibodies to treat complement-mediated neurodegenerative diseases
domain founded_year HQ Location
Drug candidates for immune-mediated diseases are developed by Aldeyra.
domain founded_year HQ Location
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
domain founded_year HQ Location
Mobile SDK developed for app engagement and monetization strategies.
domain founded_year HQ Location
Gene therapies for ocular and neurodegenerative diseases are developed.
domain founded_year HQ Location
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aciex Therapeutics

Frequently Asked Questions about Aciex Therapeutics

When was Aciex Therapeutics founded?

Aciex Therapeutics was founded in 2007 and raised its 1st funding round 4 years after it was founded.

Where is Aciex Therapeutics located?

Aciex Therapeutics is headquartered in Westborough, United States. It is registered at Westborough, Massachusetts, United States.

Is Aciex Therapeutics a funded company?

Aciex Therapeutics is a funded company, having raised a total of $9.6M across 2 funding rounds to date. The company's 1st funding round was a Series A of $8M, raised on Aug 02, 2011.

What does Aciex Therapeutics do?

Aciex Therapeutics was founded in 2007 and based in Westborough, United States. Focus was placed on therapeutic ophthalmology, with a pipeline that included treatments for allergic conjunctivitis, post-operative inflammation and pain, and topical ophthalmic products developed in partnership with Portola Pharmaceuticals. Additional indications were targeted among others. The company was acquired by Nicox in July 2014.

Who are the top competitors of Aciex Therapeutics?

Aciex Therapeutics's top competitors include Annexon, Alimera Sciences and MeiraGTx.

Who are Aciex Therapeutics's investors?

Aciex Therapeutics has 2 investors. Key investors include Nicox, and Akorn.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available